Fair Trade Commission conducts on-site investigation into Daewoong Pharmaceutical for alleged ‘unfair support’ to affiliates

Reporter Kim Jisun / approved : 2023-11-01 00:50:15
  • -
  • +
  • 인쇄
 

 

[Alpha Biz=(Chicago) Reporter Kim Jisun] The Fair Trade Commission has launched an on-site investigation after finding circumstantial evidence that Daewoong Pharmaceutical unfairly supported its group affiliates.

According to related industries on the 31st, the FTC sent investigators to Daewoong Pharmaceutical the previous day to secure data on unfair internal support.

The FTC has recently detected and is investigating allegations of unfair internal transactions by a number of companies in monitoring the status of internal transactions by mid-sized business groups.

The FTC also announced in its business plan at the beginning of the year that it will intensively monitor the expedient transfer of wealth for the succession of management rights, unfair support encroaching on the competitiveness of independent and small and medium-sized enterprises, and unfair support for insolvent affiliates.

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

어플

주요기사

Bithumb Faces ‘Book-Entry Trading’ Concerns After Miscrediting Hundreds of Thousands of Bitcoins2026.02.07
Kolmar Korea Certified as Year’s First ‘Reshoring’ Company; To Invest 100 Billion KRW in Smart Factory Expansion2026.02.06
Court Dismisses Additional Lawsuits by Shareholders Over "Invossa" Controversy, Ruling in Favor of Kolon2026.02.06
Nvidia Delays China H200 Chip Exports Amid Ongoing Talks With U.S. Government2026.02.06
Naver Issues Formal Apology Over Exposure of Celebrities’ and Politicians’ Past "Ji-sik-iN" Posts2026.02.06
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사